Viewing Study NCT03608761


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-06 @ 12:55 PM
Study NCT ID: NCT03608761
Status: COMPLETED
Last Update Posted: 2018-12-04
First Post: 2018-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Between Rebamipide 2% Versus Autologous Serum
Sponsor: Hospital Nacional Profesor Alejandro Posadas
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module